FI109796B - Metallialkoksidit - Google Patents

Metallialkoksidit Download PDF

Info

Publication number: FI109796B
Authority: FI; Finland
Prior art keywords: solution; taxol; thf; triethylsilyl; mixture
Prior art date: 1991-09-23

Application number

FI941323A

Other languages

English (en)

Finnish (fi)

Swedish (sv)

Other versions

FI941323A0 (fi

FI941323L (fi

Inventor

Robert A Holton

Original Assignee

Univ Florida State

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-23

Filing date

1994-03-22

Publication date

2002-10-15

1994-03-22 Application filed by Univ Florida State filed Critical Univ Florida State

1994-03-22 Publication of FI941323A0 publication Critical patent/FI941323A0/fi

1994-03-22 Publication of FI941323L publication Critical patent/FI941323L/fi

2002-10-15 Application granted granted Critical

2002-10-15 Publication of FI109796B publication Critical patent/FI109796B/fi

Links

229910052751 metal Inorganic materials 0.000 title claims abstract description 26
239000002184 metal Substances 0.000 title claims abstract description 26
150000004703 alkoxides Chemical class 0.000 claims abstract description 20
125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 15
125000006239 protecting group Chemical group 0.000 claims abstract description 14
-1 1-ethoxyethyl Chemical group 0.000 claims description 44
229910052744 lithium Inorganic materials 0.000 claims description 10
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 6
229910052700 potassium Inorganic materials 0.000 claims description 6
229910052708 sodium Inorganic materials 0.000 claims description 6
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
229910052749 magnesium Inorganic materials 0.000 claims description 4
229910052719 titanium Inorganic materials 0.000 claims description 3
150000004682 monohydrates Chemical group 0.000 claims 1
125000005106 triarylsilyl group Chemical group 0.000 claims 1
238000002360 preparation method Methods 0.000 abstract description 22
YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 abstract description 19
239000001257 hydrogen Substances 0.000 abstract description 14
229910052739 hydrogen Inorganic materials 0.000 abstract description 14
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract description 5
150000004200 baccatin III derivatives Chemical class 0.000 abstract description 4
229910052723 transition metal Inorganic materials 0.000 abstract description 3
150000003624 transition metals Chemical class 0.000 abstract description 3
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 80
XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 60
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 40
229930012538 Paclitaxel Natural products 0.000 description 39
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 38
229960001592 paclitaxel Drugs 0.000 description 38
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 35
239000000203 mixture Substances 0.000 description 30
OVMSOCFBDVBLFW-VHLOTGQHSA-N 5beta,20-epoxy-1,7beta,13alpha-trihydroxy-9-oxotax-11-ene-2alpha,4alpha,10beta-triyl 4,10-diacetate 2-benzoate Chemical compound O([C@@H]1[C@@]2(C[C@H](O)C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)O)C(=O)C1=CC=CC=C1 OVMSOCFBDVBLFW-VHLOTGQHSA-N 0.000 description 26
125000003118 aryl group Chemical group 0.000 description 25
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 18
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 16
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 16
229920006395 saturated elastomer Polymers 0.000 description 16
150000003952 β-lactams Chemical class 0.000 description 16
125000000217 alkyl group Chemical group 0.000 description 15
238000000034 method Methods 0.000 description 15
238000006243 chemical reaction Methods 0.000 description 14
238000001704 evaporation Methods 0.000 description 14
230000008020 evaporation Effects 0.000 description 14
229930014667 baccatin III Natural products 0.000 description 13
125000000304 alkynyl group Chemical group 0.000 description 12
238000003818 flash chromatography Methods 0.000 description 12
125000003342 alkenyl group Chemical group 0.000 description 11
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
230000015572 biosynthetic process Effects 0.000 description 9
125000001072 heteroaryl group Chemical group 0.000 description 9
239000012044 organic layer Substances 0.000 description 9
125000001424 substituent group Chemical group 0.000 description 9
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 8
238000001953 recrystallisation Methods 0.000 description 8
229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
235000017557 sodium bicarbonate Nutrition 0.000 description 8
238000003786 synthesis reaction Methods 0.000 description 8
DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 8
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
230000008569 process Effects 0.000 description 7
239000002904 solvent Substances 0.000 description 7
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
239000000463 material Substances 0.000 description 6
239000002243 precursor Substances 0.000 description 6
239000011734 sodium Substances 0.000 description 6
229940123237 Taxane Drugs 0.000 description 5
150000002431 hydrogen Chemical class 0.000 description 5
YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 5
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
150000002902 organometallic compounds Chemical class 0.000 description 5
229930190007 Baccatin Natural products 0.000 description 4
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 description 4
125000002252 acyl group Chemical group 0.000 description 4
125000006242 amine protecting group Chemical group 0.000 description 4
125000004432 carbon atom Chemical group C* 0.000 description 4
150000001875 compounds Chemical class 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
150000002148 esters Chemical group 0.000 description 4
FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 4
ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
239000011591 potassium Substances 0.000 description 4
229940063683 taxotere Drugs 0.000 description 4
125000003396 thiol group Chemical group [H]S* 0.000 description 4
125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 3
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
239000002253 acid Substances 0.000 description 3
239000002246 antineoplastic agent Substances 0.000 description 3
239000011777 magnesium Substances 0.000 description 3
229910052760 oxygen Inorganic materials 0.000 description 3
150000004579 taxol derivatives Chemical class 0.000 description 3
239000010936 titanium Substances 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
SVGIEMHCAPRHEZ-SJORKVTESA-N (3s,4r)-1-benzoyl-3-(2-methoxypropan-2-yloxy)-4-phenylazetidin-2-one Chemical compound N1([C@@H]([C@@H](C1=O)OC(C)(C)OC)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 SVGIEMHCAPRHEZ-SJORKVTESA-N 0.000 description 2
XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
241000202349 Taxus brevifolia Species 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
125000004423 acyloxy group Chemical group 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000008901 benefit Effects 0.000 description 2
XGIUDIMNNMKGDE-UHFFFAOYSA-N bis(trimethylsilyl)azanide Chemical compound C[Si](C)(C)[N-][Si](C)(C)C XGIUDIMNNMKGDE-UHFFFAOYSA-N 0.000 description 2
GWXLDORMOJMVQZ-UHFFFAOYSA-N cerium Chemical compound [Ce] GWXLDORMOJMVQZ-UHFFFAOYSA-N 0.000 description 2
239000007795 chemical reaction product Substances 0.000 description 2
DCFKHNIGBAHNSS-UHFFFAOYSA-N chloro(triethyl)silane Chemical compound CC[Si](Cl)(CC)CC DCFKHNIGBAHNSS-UHFFFAOYSA-N 0.000 description 2
230000008878 coupling Effects 0.000 description 2
238000010168 coupling process Methods 0.000 description 2
230000000694 effects Effects 0.000 description 2
125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
238000001914 filtration Methods 0.000 description 2
AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
239000000047 product Substances 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
239000000126 substance Substances 0.000 description 2
238000010189 synthetic method Methods 0.000 description 2
SKJSIVQEPKBFTJ-HUWILPJBSA-N taxusin Chemical compound C1[C@@H](C2(C)C)C[C@H](OC(C)=O)C(C)=C2[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@]2(C)CC[C@H](OC(=O)C)C(=C)[C@@H]12 SKJSIVQEPKBFTJ-HUWILPJBSA-N 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
239000011701 zinc Substances 0.000 description 2
229910052726 zirconium Inorganic materials 0.000 description 2
HZDNNJABYXNPPV-UHFFFAOYSA-N (2-chloro-2-oxoethyl) acetate Chemical compound CC(=O)OCC(Cl)=O HZDNNJABYXNPPV-UHFFFAOYSA-N 0.000 description 1
XSYLUBKWRZCOQP-QIWLAUOQSA-N (3s,4r)-1-benzoyl-3-(1-ethoxyethoxy)-4-phenylazetidin-2-one Chemical compound N1([C@@H]([C@@H](C1=O)OC(C)OCC)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 XSYLUBKWRZCOQP-QIWLAUOQSA-N 0.000 description 1
PMFXBVOLZORTNG-UXHICEINSA-N (3s,4r)-1-benzoyl-4-phenyl-3-triethylsilyloxyazetidin-2-one Chemical compound N1([C@@H]([C@@H](C1=O)O[Si](CC)(CC)CC)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 PMFXBVOLZORTNG-UXHICEINSA-N 0.000 description 1
MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 description 1
UUFQTNFCRMXOAE-UHFFFAOYSA-N 1-methylmethylene Chemical compound C[CH] UUFQTNFCRMXOAE-UHFFFAOYSA-N 0.000 description 1
229930182986 10-Deacetyltaxol Natural products 0.000 description 1
PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
FVXIPVHDRCDSRW-UHFFFAOYSA-N 2-[6-methoxy-6-(trifluoromethyl)cyclohexa-2,4-dien-1-yl]acetic acid Chemical class COC1(C(F)(F)F)C=CC=CC1CC(O)=O FVXIPVHDRCDSRW-UHFFFAOYSA-N 0.000 description 1
LIJLYNWYKULUHA-UHFFFAOYSA-N 2-chloroethyl carbamate Chemical compound NC(=O)OCCCl LIJLYNWYKULUHA-UHFFFAOYSA-N 0.000 description 1
LUYQINUDJUXWNB-UHFFFAOYSA-N 3-(1-ethoxyethoxy)-4-phenylazetidin-2-one Chemical compound N1C(=O)C(OC(C)OCC)C1C1=CC=CC=C1 LUYQINUDJUXWNB-UHFFFAOYSA-N 0.000 description 1
125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
101100231508 Caenorhabditis elegans ceh-5 gene Proteins 0.000 description 1
101100028482 Caenorhabditis elegans pal-1 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229910052684 Cerium Inorganic materials 0.000 description 1
XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
101100108327 Escherichia coli (strain K12) melA gene Proteins 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
241000779819 Syncarpia glomulifera Species 0.000 description 1
241001116498 Taxus baccata Species 0.000 description 1
235000009065 Taxus cuspidata Nutrition 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
150000001241 acetals Chemical class 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
229910052768 actinide Inorganic materials 0.000 description 1
150000001255 actinides Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
150000001263 acyl chlorides Chemical class 0.000 description 1
125000003545 alkoxy group Chemical group 0.000 description 1
150000001350 alkyl halides Chemical class 0.000 description 1
HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
125000003368 amide group Chemical group 0.000 description 1
150000001408 amides Chemical class 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
229910052786 argon Inorganic materials 0.000 description 1
239000012300 argon atmosphere Substances 0.000 description 1
239000003849 aromatic solvent Substances 0.000 description 1
125000005104 aryl silyl group Chemical group 0.000 description 1
125000004429 atom Chemical group 0.000 description 1
PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
229910052796 boron Inorganic materials 0.000 description 1
125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
150000004657 carbamic acid derivatives Chemical class 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
DLNKOYKMWOXYQA-IONNQARKSA-N cathine Chemical compound C[C@H](N)[C@@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-IONNQARKSA-N 0.000 description 1
229960003609 cathine Drugs 0.000 description 1
XMPZTFVPEKAKFH-UHFFFAOYSA-P ceric ammonium nitrate Chemical compound [NH4+].[NH4+].[Ce+4].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O XMPZTFVPEKAKFH-UHFFFAOYSA-P 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
HPNSNYBUADCFDR-UHFFFAOYSA-N chromafenozide Chemical compound CC1=CC(C)=CC(C(=O)N(NC(=O)C=2C(=C3CCCOC3=CC=2)C)C(C)(C)C)=C1 HPNSNYBUADCFDR-UHFFFAOYSA-N 0.000 description 1
239000000039 congener Substances 0.000 description 1
239000012043 crude product Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
230000032050 esterification Effects 0.000 description 1
238000005886 esterification reaction Methods 0.000 description 1
150000002170 ethers Chemical class 0.000 description 1
125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
150000004820 halides Chemical class 0.000 description 1
125000006038 hexenyl group Chemical group 0.000 description 1
125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
125000005980 hexynyl group Chemical group 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
150000002466 imines Chemical class 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
229910010272 inorganic material Inorganic materials 0.000 description 1
125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
229910052747 lanthanoid Inorganic materials 0.000 description 1
150000002602 lanthanoids Chemical class 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
PKMBLJNMKINMSK-UHFFFAOYSA-N magnesium;azanide Chemical class [NH2-].[NH2-].[Mg+2] PKMBLJNMKINMSK-UHFFFAOYSA-N 0.000 description 1
NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
FRIJBUGBVQZNTB-UHFFFAOYSA-M magnesium;ethane;bromide Chemical compound [Mg+2].[Br-].[CH2-]C FRIJBUGBVQZNTB-UHFFFAOYSA-M 0.000 description 1
229910001507 metal halide Inorganic materials 0.000 description 1
150000005309 metal halides Chemical class 0.000 description 1
125000005911 methyl carbonate group Chemical class 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
XBXCNNQPRYLIDE-UHFFFAOYSA-M n-tert-butylcarbamate Chemical compound CC(C)(C)NC([O-])=O XBXCNNQPRYLIDE-UHFFFAOYSA-M 0.000 description 1
125000001624 naphthyl group Chemical group 0.000 description 1
150000002900 organolithium compounds Chemical class 0.000 description 1
125000002734 organomagnesium group Chemical group 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
239000001739 pinus spp. Substances 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000000746 purification Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
230000003595 spectral effect Effects 0.000 description 1
239000007858 starting material Substances 0.000 description 1
YALHCTUQSQRCSX-UHFFFAOYSA-N sulfane sulfuric acid Chemical compound S.OS(O)(=O)=O YALHCTUQSQRCSX-UHFFFAOYSA-N 0.000 description 1
YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
230000029305 taxis Effects 0.000 description 1
125000006633 tert-butoxycarbonylamino group Chemical group 0.000 description 1
125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
AWQUYUAEGSCHBU-UHFFFAOYSA-N tert-butyl n-chlorocarbamate Chemical compound CC(C)(C)OC(=O)NCl AWQUYUAEGSCHBU-UHFFFAOYSA-N 0.000 description 1
150000003512 tertiary amines Chemical class 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000007970 thio esters Chemical class 0.000 description 1
125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 description 1
125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
230000001875 tumorinhibitory effect Effects 0.000 description 1
229940036248 turpentine Drugs 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/003—Compounds containing elements of Groups 4 or 14 of the Periodic Table without C-Metal linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epoxy Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Glass Compositions (AREA)
Saccharide Compounds (AREA)
Silicates, Zeolites, And Molecular Sieves (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Compositions Of Oxide Ceramics (AREA)
Crystals, And After-Treatments Of Crystals (AREA)

FI941323A 1991-09-23 1994-03-22 Metallialkoksidit FI109796B (fi)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US76380591A	1991-09-23	1991-09-23
US76380591		1991-09-23
US86277892		1992-04-03
US07/862,778 US5229526A (en)	1991-09-23	1992-04-03	Metal alkoxides
US9207952		1992-09-22
PCT/US1992/007952 WO1993006094A1 (en)	1991-09-23	1992-09-22	Metal alkoxides

Publications (3)

Publication Number	Publication Date
FI941323A0 FI941323A0 (fi)	1994-03-22
FI941323L FI941323L (fi)	1994-03-22
FI109796B true FI109796B (fi)	2002-10-15

Family

ID=27117339

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI941323A FI109796B (fi)	1991-09-23	1994-03-22	Metallialkoksidit

Country Status (24)

Country	Link
US (1)	US5229526A (da)
EP (1)	EP0605638B1 (da)
JP (1)	JP3320416B2 (da)
CN (1)	CN1058714C (da)
AT (1)	ATE184004T1 (da)
AU (1)	AU643911B2 (da)
CA (1)	CA2098568C (da)
CZ (1)	CZ289299B6 (da)
DE (1)	DE69229916T2 (da)
DK (1)	DK0605638T3 (da)
ES (1)	ES2137951T3 (da)
FI (1)	FI109796B (da)
HU (1)	HU225914B1 (da)
IL (1)	IL103192A (da)
MX (1)	MX9205370A (da)
MY (1)	MY128481A (da)
NO (1)	NO305120B1 (da)
NZ (1)	NZ244458A (da)
PH (1)	PH30213A (da)
PT (1)	PT100884B (da)
RU (1)	RU2098413C1 (da)
TW (1)	TW368502B (da)
UA (1)	UA41287C2 (da)
WO (1)	WO1993006094A1 (da)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6018073A (en) *	1991-09-23	2000-01-25	Florida State University	Tricyclic taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US6495704B1 (en)	1991-09-23	2002-12-17	Florida State University	9-desoxotaxanes and process for the preparation of 9-desoxotaxanes
US6335362B1 (en)	1991-09-23	2002-01-01	Florida State University	Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
US5714513A (en) *	1991-09-23	1998-02-03	Florida State University	C10 taxane derivatives and pharmaceutical compositions
US6794523B2 (en)	1991-09-23	2004-09-21	Florida State University	Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
US5710287A (en)	1991-09-23	1998-01-20	Florida State University	Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them
US5739362A (en) *	1991-09-23	1998-04-14	Florida State University	Taxanes having an alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing them
US5489601A (en) *	1991-09-23	1996-02-06	Florida State University	Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
US7074945B2 (en) *	1991-09-23	2006-07-11	Florida State University	Metal alkoxide taxane derivatives
US5430160A (en) *	1991-09-23	1995-07-04	Florida State University	Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides
ZA926829B (en) *	1991-09-23	1993-03-15	Univ Florida State	Novel substituted taxanes and pharmaceutical compositions containing them.
US5728725A (en) *	1991-09-23	1998-03-17	Florida State University	C2 taxane derivaties and pharmaceutical compositions containing them
US5284865A (en) *	1991-09-23	1994-02-08	Holton Robert A	Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
US6028205A (en) *	1991-09-23	2000-02-22	Florida State University	C2 tricyclic taxanes
US6005138A (en)	1991-09-23	1999-12-21	Florida State University	Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US5721268A (en) *	1991-09-23	1998-02-24	Florida State University	C7 taxane derivatives and pharmaceutical compositions containing them
US5728850A (en) *	1991-09-23	1998-03-17	Florida State University	Taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
US6011056A (en) *	1991-09-23	2000-01-04	Florida State University	C9 taxane derivatives and pharmaceutical compositions containing them
US5998656A (en) *	1991-09-23	1999-12-07	Florida State University	C10 tricyclic taxanes
US6521660B2 (en)	1991-09-23	2003-02-18	Florida State University	3′-alkyl substituted taxanes and pharmaceutical compositions containing them
US5294637A (en) *	1992-07-01	1994-03-15	Bristol-Myers Squibb Company	Fluoro taxols
US5614549A (en) *	1992-08-21	1997-03-25	Enzon, Inc.	High molecular weight polymer-based prodrugs
FR2697752B1 (fr) *	1992-11-10	1995-04-14	Rhone Poulenc Rorer Sa	Compositions antitumorales contenant des dérivés du taxane.
FR2698363B1 (fr) *	1992-11-23	1994-12-30	Rhone Poulenc Rorer Sa	Nouveaux dérivés du taxane, leur préparation et les compositions qui les contiennent.
US5380751A (en) *	1992-12-04	1995-01-10	Bristol-Myers Squibb Company	6,7-modified paclitaxels
FR2698871B1 (fr)	1992-12-09	1995-02-24	Rhone Poulenc Rorer Sa	Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5646176A (en)	1992-12-24	1997-07-08	Bristol-Myers Squibb Company	Phosphonooxymethyl ethers of taxane derivatives
CA2153903C (en) *	1993-01-15	2004-11-02	Robert A. Holton	Process for the preparation of 10-desacetoxybaccatin iii
US6187916B1 (en) *	1993-02-01	2001-02-13	Research Foundation Of State University Of New York	Process for the preparation of taxane derivatives and β-lactam intermediates therefor
US6593482B2 (en)	1993-02-01	2003-07-15	Aventis Pharma S.A.	Methods for preparing new taxoids and pharmaceutical compositions containing them
ZA94128B (en) *	1993-02-01	1994-08-19	Univ New York State Res Found	Process for the preparation of taxane derivatives and betalactam intermediates therefor
US6710191B2 (en)	1993-03-05	2004-03-23	Florida State University	9β-hydroxytetracyclic taxanes
ES2193154T3 (es) *	1993-03-05	2003-11-01	Univ Florida State	Procedimiento para la preparacion de 9-desoxotaxanos.
US5547981A (en) *	1993-03-09	1996-08-20	Enzon, Inc.	Taxol-7-carbazates
TW467896B (en) *	1993-03-19	2001-12-11	Bristol Myers Squibb Co	Novel β-lactams, methods for the preparation of taxanes and sidechain-bearing taxanes
IL109049A (en) *	1993-03-22	2006-12-31	Univ Florida State	Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them
FR2703049B1 (fr) *	1993-03-22	1995-04-21	Rhone Poulenc Rorer Sa	Procédé de purification des taxoïdes.
PT689436E (pt) *	1993-03-22	2004-04-30	Univ Florida State	Taxanos que nao possuem um grupo oxo em c-9 e composicoes farmaceuticas que os contem
IT1261667B (it) *	1993-05-20	1996-05-29		Tassano ad attivita' antitumorale.
CN1704121B (zh)	1993-07-19	2010-08-18	血管技术药物公司	抗血管生长组合物及使用方法
US5405972A (en) *	1993-07-20	1995-04-11	Florida State University	Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes
US6005120A (en)	1993-07-20	1999-12-21	Florida State University	Tricyclic and tetracyclic taxanes
CA2129288C (en) *	1993-08-17	2000-05-16	Jerzy Golik	Phosphonooxymethyl esters of taxane derivatives
US5880131A (en) *	1993-10-20	1999-03-09	Enzon, Inc.	High molecular weight polymer-based prodrugs
US5965566A (en) *	1993-10-20	1999-10-12	Enzon, Inc.	High molecular weight polymer-based prodrugs
US5622986A (en) *	1993-10-20	1997-04-22	Enzon, Inc.	2'-and/or 7-substituted taxanes
US6441026B1 (en)	1993-11-08	2002-08-27	Aventis Pharma S.A.	Antitumor compositions containing taxane derivatives
FR2718137B1 (fr) *	1994-04-05	1996-04-26	Rhone Poulenc Rorer Sa	Procédé de préparation de trialcoylsilyl-7 baccatine III.
FR2722191B1 (fr) *	1994-07-08	1996-08-23	Rhone Poulenc Rorer Sa	Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US6201140B1 (en)	1994-07-28	2001-03-13	Bristol-Myers Squibb Company	7-0-ethers of taxane derivatives
US6500858B2 (en)	1994-10-28	2002-12-31	The Research Foundation Of The State University Of New York	Taxoid anti-tumor agents and pharmaceutical compositions thereof
US6458976B1 (en)	1994-10-28	2002-10-01	The Research Foundation Of State University Of New York	Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods
US6100411A (en) *	1994-10-28	2000-08-08	The Research Foundation Of State University Of New York	Taxoid anti-tumor agents and pharmaceutical compositions thereof
JPH10508022A (ja) *	1994-10-28	1998-08-04	ザリサーチファウンデーションオブステートユニバーシティオブニューヨーク	タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US5847170A (en) *	1995-03-27	1998-12-08	Rhone-Poulenc Rorer, S.A.	Taxoids, their preparation and pharmaceutical compositions containing them
US6372780B2 (en)	1995-03-27	2002-04-16	Aventis Pharma S.A.	Methods of treating cell lines expressing multidrug resistance P-glycoprotein
MA23823A1 (fr)	1995-03-27	1996-10-01	Aventis Pharma Sa	Nouveaux taxoides, leur preparation et les compositions qui les contiennent
US5760251A (en) *	1995-08-11	1998-06-02	Sepracor, Inc.	Taxol process and compounds
EP0855909A4 (en) *	1995-09-13	2000-06-07	Univ Florida State	TAXANES WITH RADIOSENSITIZING EFFECT AND THEIR PHARMACEUTICAL PREPARATIONS
US5840748A (en) *	1995-10-02	1998-11-24	Xechem International, Inc.	Dihalocephalomannine and methods of use therefor
US6177456B1 (en)	1995-10-02	2001-01-23	Xechem International, Inc.	Monohalocephalomannines having anticancer and antileukemic activity and method of preparation therefor
US5854278A (en) *	1995-12-13	1998-12-29	Xechem International, Inc.	Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
US5807888A (en) *	1995-12-13	1998-09-15	Xechem International, Inc.	Preparation of brominated paclitaxel analogues and their use as effective antitumor agents
US5654448A (en) *	1995-10-02	1997-08-05	Xechem International, Inc.	Isolation and purification of paclitaxel from organic matter containing paclitaxel, cephalomannine and other related taxanes
WO1997042181A1 (en) *	1996-05-06	1997-11-13	Florida State University	1-deoxy baccatin iii, 1-deoxy taxol and 1-deoxy taxol analogs and method for the preparation thereof
US5635531A (en) *	1996-07-08	1997-06-03	Bristol-Myers Squibb Company	3'-aminocarbonyloxy paclitaxels
US5750736A (en) *	1996-07-11	1998-05-12	Napro Biotherapeutics, Inc.	Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
US5750737A (en) *	1996-09-25	1998-05-12	Sisti; Nicholas J.	Method for paclitaxel synthesis
US5973170A (en) *	1996-09-25	1999-10-26	Napro Biotherapuetics, Inc.	C-7 metal alkoxides of baccatin III
US5912264A (en) *	1997-03-03	1999-06-15	Bristol-Myers Squibb Company	6-halo-or nitrate-substituted paclitaxels
US6017935A (en) *	1997-04-24	2000-01-25	Bristol-Myers Squibb Company	7-sulfur substituted paclitaxels
US7288665B1 (en) *	1997-08-18	2007-10-30	Florida State University	Process for selective derivatization of taxanes
US5917062A (en) *	1997-11-21	1999-06-29	Indena S.P.A	Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
US5914411A (en) *	1998-01-21	1999-06-22	Napro Biotherapeutics, Inc.	Alternate method for acylating 10-deacetylbaccatin III selectively at the C-10 position
US6156789A (en) *	1998-03-17	2000-12-05	Rhone-Poulenc Rorer S.A.	Method for treating abnormal cell proliferation in the brain
US6066749A (en) *	1998-05-01	2000-05-23	Napro Biotherapeutics, Inc.	Method for conversion of C-2'-O-protected-10-hydroxy taxol to c-2'-O-protected taxol:useful intermediates in paclitaxel synthesis
ATE269854T1 (de)	1998-05-01	2004-07-15	Napro Biotherapeutics Inc	Verfahren und verwendbare zwischenprodukte für paclitaxel synthese von c-7,c-10 di-cbz baccatin iii
US6048990A (en) *	1998-05-01	2000-04-11	Napro Biotherapeutics, Inc.	Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
US6025516A (en) *	1998-10-14	2000-02-15	Chiragene, Inc.	Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
US6136999A (en) *	1999-06-21	2000-10-24	Napro Biotherapeutics, Inc.	C-2 hydroxyl protected-n-acyl (2R,3S)-3-phenylisoserine substituted phenyl activated esters and method for production thereof
US6143902A (en) *	1999-06-21	2000-11-07	Napro Biotherapeutics, Inc.	C-2 hydroxyl protected-N-acyl (2R,3S)-3-phenylisoserine N-imido activated esters and method for production thereof
WO2001024763A2 (en)	1999-10-01	2001-04-12	Immunogen, Inc.	Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6548293B1 (en)	1999-10-18	2003-04-15	Fsu Research Foundation, Inc.	Enzymatic process for the resolution of enantiomeric mixtures of β-lactams
US7063977B2 (en) *	2001-08-21	2006-06-20	Bristol-Myers Squibb Company	Enzymatic resolution of t-butyl taxane derivatives
HUP0600533A2 (en) *	2001-11-30	2006-11-28	Bristol Myers Squibb Co	Paclitaxel solvates
US6703599B1 (en) *	2002-01-30	2004-03-09	Microsoft Corporation	Proximity sensor with adaptive threshold
EP1562927B1 (en) *	2002-10-09	2009-05-13	Chatham Biotec Ltd.	Thio-analogues of paclitaxel and intermediates thereof
US7030253B2 (en) *	2003-08-07	2006-04-18	Bristol-Myers Squibb Company	Process for preparing 4-alkyl- or 4-aryl-oxycarbonyl paclitaxel analogs and novel intermediates
US7202370B2 (en) *	2003-10-27	2007-04-10	Conor Medsystems, Inc.	Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
US20050272807A1 (en) *	2004-06-04	2005-12-08	Phytogen Life Sciences Inc.	Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
US20050288520A1 (en) *	2004-06-25	2005-12-29	Phytogen Life Sciences Inc.	One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
JP2006302679A (ja) *	2005-04-21	2006-11-02	Seiko Epson Corp	導電膜の形成方法、及び電子機器の製造方法
WO2006116532A2 (en) *	2005-04-28	2006-11-02	University Of Massachusetts Lowell	Synthesis of oligo/poly(catechins) and methods of use
KR101266549B1 (ko) *	2006-10-20	2013-05-24	시노팜 싱가포르 피티이 리미티드	결정형 무수 도세탁셀을 제조하는 방법
CN101289432B (zh) *	2007-04-20	2010-12-15	上海天伟生物制药有限公司	异丝氨酸酯衍生物及其制备方法
EP2285792A2 (en) *	2008-05-07	2011-02-23	Ivax Research, Llc	Processes for preparation of taxanes and intermediates thereof
KR101096282B1 (ko)	2009-04-24	2011-12-20	주식회사 삼양제넥스	탁산 유도체를 제조하는 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Procede de preparation du taxol et du desacetyl-10 taxol
US4942184A (en) *	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
FR2629819B1 (fr) *	1988-04-06	1990-11-16	Rhone Poulenc Sante	Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) *	1988-04-06	1990-11-16	Centre Nat Rech Scient	Procede de preparation du taxol
US5015744A (en) *	1989-11-14	1991-05-14	Florida State University	Method for preparation of taxol using an oxazinone

1992
- 1992-04-03 US US07/862,778 patent/US5229526A/en not_active Expired - Lifetime
- 1992-09-16 IL IL103192A patent/IL103192A/xx not_active IP Right Cessation
- 1992-09-21 PH PH44959A patent/PH30213A/en unknown
- 1992-09-21 MY MYPI92001683A patent/MY128481A/en unknown
- 1992-09-21 PT PT100884A patent/PT100884B/pt active IP Right Grant
- 1992-09-22 RU RU9494019168A patent/RU2098413C1/ru not_active IP Right Cessation
- 1992-09-22 JP JP50627793A patent/JP3320416B2/ja not_active Expired - Fee Related
- 1992-09-22 EP EP92921317A patent/EP0605638B1/en not_active Expired - Lifetime
- 1992-09-22 AT AT92921317T patent/ATE184004T1/de not_active IP Right Cessation
- 1992-09-22 CA CA002098568A patent/CA2098568C/en not_active Expired - Fee Related
- 1992-09-22 DE DE69229916T patent/DE69229916T2/de not_active Expired - Fee Related
- 1992-09-22 DK DK92921317T patent/DK0605638T3/da active
- 1992-09-22 AU AU26888/92A patent/AU643911B2/en not_active Ceased
- 1992-09-22 WO PCT/US1992/007952 patent/WO1993006094A1/en active IP Right Grant
- 1992-09-22 HU HU9400831A patent/HU225914B1/hu not_active IP Right Cessation
- 1992-09-22 ES ES92921317T patent/ES2137951T3/es not_active Expired - Lifetime
- 1992-09-22 UA UA94005359A patent/UA41287C2/uk unknown
- 1992-09-22 MX MX9205370A patent/MX9205370A/es not_active IP Right Cessation
- 1992-09-22 CZ CZ1994662A patent/CZ289299B6/cs not_active IP Right Cessation
- 1992-09-23 CN CN92112482A patent/CN1058714C/zh not_active Expired - Fee Related
- 1992-09-23 NZ NZ244458A patent/NZ244458A/en not_active IP Right Cessation
- 1992-10-21 TW TW081108376A patent/TW368502B/zh not_active IP Right Cessation
1994
- 1994-03-22 FI FI941323A patent/FI109796B/fi active
- 1994-03-22 NO NO941020A patent/NO305120B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL103192A0 (en)	1993-02-21
DK0605638T3 (da)	2000-02-28
JPH07502982A (ja)	1995-03-30
CN1058714C (zh)	2000-11-22
JP3320416B2 (ja)	2002-09-03
PT100884A (pt)	1993-11-30
NO305120B1 (no)	1999-04-06
NZ244458A (en)	1994-06-27
AU643911B2 (en)	1993-11-25
FI941323A0 (fi)	1994-03-22
FI941323L (fi)	1994-03-22
HUT66398A (en)	1994-11-28
TW368502B (en)	1999-09-01
PT100884B (pt)	1999-07-30
NO941020L (no)	1994-05-20
CA2098568C (en)	1997-06-03
US5229526A (en)	1993-07-20
CZ66294A3 (en)	1994-12-15
PH30213A (en)	1997-02-05
MX9205370A (es)	1993-03-31
CA2098568A1 (en)	1993-03-24
UA41287C2 (uk)	2001-09-17
ES2137951T3 (es)	2000-01-01
CN1075718A (zh)	1993-09-01
AU2688892A (en)	1993-04-27
DE69229916D1 (de)	1999-10-07
DE69229916T2 (de)	2000-02-17
HU9400831D0 (en)	1994-06-28
RU2098413C1 (ru)	1997-12-10
NO941020D0 (no)	1994-03-22
HU225914B1 (en)	2007-12-28
IL103192A (en)	1997-06-10
WO1993006094A1 (en)	1993-04-01
EP0605638B1 (en)	1999-09-01
EP0605638A1 (en)	1994-07-13
CZ289299B6 (cs)	2001-12-12
MY128481A (en)	2007-02-28
EP0605638A4 (en)	1994-08-24
ATE184004T1 (de)	1999-09-15

Publication	Publication Date	Title
FI109796B (fi)	2002-10-15	Metallialkoksidit
US5274124A (en)	1993-12-28	Metal alkoxides
US5254703A (en)	1993-10-19	Semi-synthesis of taxane derivatives using metal alkoxides and oxazinones
US6653490B2 (en)	2003-11-25	Process for the preparation of ammonium alkoxides
US5723634A (en)	1998-03-03	Metal alkoxide compounds
KR0161499B1 (ko)	1998-12-01	옥사지논을 사용하는 탁솔의 제조방법
EP1193252B1 (en)	2006-12-27	Beta-Lactams useful for preparation of substituted isoserine esters using metal alkoxides
CN1057082C (zh)	2000-10-04	紫杉酚的制备方法
US20040073048A1 (en)	2004-04-15	Perparation of substituted isoserine esters using metal alkoxides and beta-lactams
PT100883B (pt)	1999-07-30	Processo para a preparacao de derivados de taxano utilizando alcoxidos metalicos e b-lactamas